Skip to contentS
Sensus Healthcare, Inc.
S
SRTSSensus Healthcare, Inc. Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$12.57M$12.57Mderived−4.1% vs Q4 2022 Net Income$4.21M$4.21Mderived+48.8% vs Q4 2022 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sensus Healthcare, Inc. · CIK 1494891 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$7,830,000−6.2% Operating Incomederived$5,579,000+33.8% Operating Cash Flowderived$2,668,000N/M Free Cash Flowderived$2,668,000N/M Margins · derivedGross margin62.3%−1.4 pt vs Q4 2022
Operating margin44.4%+12.6 pt vs Q4 2022
Net margin33.5%+11.9 pt vs Q4 2022
ended Dec 31, 2023 · filed Mar 15, 2024 · 75 d after period end